Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

The First Affiliated Hospital With Nanjing Medical University

Clinical trials sponsored by The First Affiliated Hospital With Nanjing Medical University, explained in plain language.

Trials to join now! 37 Not yet recruiting 23 Not yet finished but already full! 3 Completed 7 Terminated 1

Experimental Dual-Target cell therapy for tough lymphoma shows early promise but study halted

Disease control Terminated

This early-phase trial tested a new cell therapy called LUCAR-G39P for people with B-cell non-Hodgkin lymphoma that had come back or stopped responding to treatment. The therapy uses a patient's own immune cells, modified to target two markers (CD19 and CD20) on cancer cells. The…

Phase: PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control

Last updated May 15, 2026 11:57 UTC